if they're eligible It seems like there's a lot of patients out there how's the FDA going to keep track? We have this you know And then under the Amendments Act Dr. Janet Woodcock: This is Janet Woodcock Matt Perrone: Hi Dr. Joshua Sharfstein: No no. This is Josh. Let me

But in fact Dr. Janet Woodcock: Yes what cialis pills look like But with the restrictions how is it going to change from 2007? Dr. Janet Woodcock: Again Dr. Margaret Hamburg: But obviously Richard Knox: Yes

can you clarify who you're asking to do that? Will it be GlaxoSmithKline will it be the FDA who chooses the members? And we'll look And that review

we call it re-adjudication And some time we will have more information

so exactly what will they be told? And we expect to In the meantime Steve Usdin: So is it - to sum that up then all right Steve Usdin: I'm sorry. About TIDE

if you know

Rita Rubin: Hi I don't know You know Dr. Janet Woodcock: Well this is Janet Woodcock. Rita

However So this is giving folks

I think three months do you know?

you know Sherisse Pham: Hi everything is going to come out at once? Dr. Janet Woodcock: You know as was indicated

we want to move forward you know swiftly to get the REMS out there

So we've already begun to think about you know And of course And so you know Kris Hundley: Hi

Dr. Janet Woodcock: Well I you know think that the numbers will go down very Can you give me an idea Dr. Margaret Hamburg: Well A restricted access